Melatonin supplementation for Sleep Disorder
Rothman Orthopaedics at Egg Harbor Township, Egg Harbor Township, NJ
melatoninN/AWaitlist AvailableResearch Sponsored by Rothman Institute OrthopaedicsEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who undergo primary ARCR
Patient willing and able to complete postoperative surveys
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up6 weeks post-surgery
Awards & highlights
No Placebo-Only Group
Study Summary
The purpose of this study is to investigate if oral melatonin reduces postoperative sleep 18 disturbances and narcotics use. We will enroll patients undergoing primary arthroscopic rotator 19 cuff repair (ARCR) at the Rothman Institute.
Eligible Conditions
- Sleep Disorder
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks post-surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pittsburg Sleep Quality Index (PSQI)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: No supplementationActive Control1 Intervention
Group II: Melatonin supplementationActive Control1 Intervention
5mg melatonin tablets to be taken for 6 weeks
Find a site
Who is running the clinical trial?
Rothman Institute OrthopaedicsLead Sponsor
116 Previous Clinical Trials
20,786 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.